STI Clinical Update Webinar - Mpox Clinical Update: What's New, What to Suspect, What to Do - Recognition & Prevention

June 2, 2026

12:00PM-1:15PM (PDT)
1.25 CME units offered at no cost

Registration closes on June 1, 2026 at 3:00PM (PDT) 

Stay current on mpox! 

This clinician-focused webinar reviews the latest U.S. and global epidemiology of mpox, including clade I. Learn how and when to suspect, diagnose, manage, and report mpox promptly and effectively.

We'll also translate the most recent vaccine recommendations into practical workflows during Pride Season and in preparation for summer travel and events.

Presenters

Eric Tang, MD, MPH

Public Health Medical Officer

Office of Sexually Transmitted Infections (STIs) and Hepatitis C Virus (HCV)

California Department of Public Health (CDPH)

Clinical Faculty, California Prevention Training Center at UCSF

Jason Zucker, MD, MS

Assistant Professor of Medicine

Columbia University Irving Medical Center

PI/Co-Medical Director

NYC STI/HIV Prevention Training Center

Learning Objectives 

• Describe the latest epidemiological trends and key developments in mpox, both in the U.S. and globally, with a particular focus on the emergence and clinical implications of clade I mpox

• Identify and diagnose mpox and know when to suspect clade I mpox, ensuring prompt and effective management

• Integrate the most recent CDPH mpox vaccine and prevention recommendations into routine clinical practice

Registration Confirmation Email with Zoom Webinar Link

• Within 24 hours of registering, you will receive a registration confirmation email from training@nnptc.org.

• Please review the contents of the confirmation, which includes important information on webinar attendance requirements, CME Overview, and Zoom link instructions. 

• We ask that you please do not share or forward any links associated with the webinar. 

• Those not registered on NNPTC who sign on to the webinar will not be counted in attendance or eligible to receive CME credit.

• To ensure you receive the NNPTC registration confirmation email, please add training@nnptc.org to your safe/trusted senders list and be sure to monitor both your inbox and spam/junk folders for the notification.

ACCME Disclosure

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and California Prevention Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians. The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. Nurses should check with their individual licensing boards to confirm the acceptability of AMA credits for the purpose of licensing renewal.

Financial Disclosure

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.

STI Overview

OBJECTIVES 

1.  Describe most recent epidemiology for reportable STIs in the United States and locally

2.  Identify the common bacterial or antibiotic treated STIs

3.  Identify the common viral STIs

4.  Describe at least 2 population factors increasing one's risk for acquisition of an STI

5.  Discuss provider skills in sexual health services3.  Identify the common viral STIs

6.  Describe the importance of interprofessional collaboration in health department and

private practice regarding STIs

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Alabama Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The University of Alabama Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mr. Gilman would like to disclose that he receives an honorarium from CME Outfitters. Ms. Dell would like to disclose that her agency gets money from Gilead Pharmaceuticals. Dr. Khalil Ghanem would like to disclose that he gets royalties from UpToDate. Dr. Rutland would like to disclose that they get a consulting fee with Gilead/ViiV, she gets an honorarium with the Mid Atlantic AIDS Education and Training Center (MAAETC), she gets support for travel to meetings and other purposes from Gilead/ViiV, she gets paid for development of education presentations from Clinical Care Options, and she also gets payment for lectures, including service on speakers bureaus from ViiV, CCO and MAAAETC.  Ms. Liang would like to disclose that their institution gets CDC money for the regional NNPTC (National Network of STD Clinical Prevention Training Centers.

There is no commercial support for this activity. 

CNE

This nursing continuing Professional Development activity was approved by the Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

There are 16.5 nursing contact hours awarded for those who attend the entire program as well as complete the evaluation for this program.

Mr. Gilman would like to disclose that he is receiving an honorarium with CME Outfitters.  Also Ms. Dell would like to disclose that their employer gets grant support from Gilead Pharmaceuticals.  

Dr. Rutland would like to disclose that she is getting a consulting fee with Gilead and on the speaker’s bureau for ViiV Pharmaceuticals.

None of the planners for this activity have relevant financial relationship(s) with ineligible companies to disclose.

The STI Clinical Single Subject Course provides participants with training in the most recent advancements in epidemiology, diagnosis, and management of viral and bacterial STIs. 

Dates: June 10th, June 17th, and June 24th, 2026
Time: 12:00-1:00pm Central Time/10:00am-11:00am Pacific Time
Location: Live Zoom Webinar

Description

These 3 sessions will address recent developments in the prevention, diagnosis and management of prevalent STDs and will concentrate on one of the following topics: Syphilis Epidemiology, Treatment, Congenital Syphilis & Syphilis in pregnancy.

Course Objectives

• Discuss the clinical management of syphilis to include treatment, follow-up and partner management
• Discuss the management of congenital syphilis
• Discuss screening recommendations
  
  

Faculty & Planning Committee Disclosures

Christine Johnston, MD, MPH (Planning Committee Chair)-
Pfizer- grant research support (ongoing)
Assembly Biosciences-consultant (ongoing), grant research support (ongoing)
AiCuris- consultant (ongoing)
Oxymo- consultant  (ongoing) 
Simplexia- consultant (ongoing)
Mitigation was completed and no conflicts were found. 

Tim Menza, MD, PhD (Faculty Presenter)- no disclosures

Continuing Medical Education Credit 

FACULTY & PLANNING COMMITTEE DISCLOSURES: 

It is the policy of the University of Washington and the UW Prevention Training Center, that the faculty, and planning committee, disclose real and apparent conflicts of interest relating to the topics in this educational activity. The UW Prevention Training Center has established policies that identify and resolve all conflicts of interest prior to the live presentation of this activity. For faculty and team information please visit: https://www.uwptc.org/ptcteam

CONTINUING MEDICAL EDUCATION: 
The University of Washington is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This training will provide a basic summary of syphilis lab diagnosis, assessment, staging, and treatment with an emphasis on pregnant patients.

Learning Objectives: By the end of this course, the learner will be able to describe the epidemiology, symptomatology, diagnosis, and treatment modalities for syphilis

Date: June 15th, 2026

Time: 8:00AM -9:00AM 

Location: Link will be in confrimation email 

1. STI Intensive

2. Learning Objectives

3. Describe current STI/HIV screening strategies including diagnostic algorithms.
4. Describe current STI/HIV treatment recommendations.
5. Describe current STI/HIV clinical management for patients and their partners.
6. Describe the importance of interprofessional collaboration in sexual health care.

AGENDA 

This one-day laboratory course is offered to clinicians to improve their ability to use a microscope to correctly identify pathogens in wet mounts (BV, candidiasis and trichomonas).  This class is limited to 10 participants. 

Objectives:

1. Discuss the parts of the Compound Light microscope.

2. Demonstrate the proper techniques for Brightfield and Darkfield microscope.

3. Describe the proper clinical techniques for the collection of genital specimens.

4. Identify Trichomonas vaginalis in saline wet preparations.

5. Identify clue cells in saline wet preparations.

6. Identify Candida species in saline and KOH wet preparations.

7. Demonstrate effective team skills by sharing information effectively, listening and responding

 to feedback from others, and using simple communication.

CME and CNE Requirements

In support of improving patient care, this activity has been planned and implemented by the UAB Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The UAB Marnix E. Heersink School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The UAB Heersink School of Medicine designates this live activity for a maximum of 6.25 ANCC contact hours.

Dr. Ghanem would like to disclose that he gets royalties from UpToDate.  All other speakers and planners do not have anything to disclose.

There is no commercial support for this activity.

*This Course will take place on June 24, 2026 from 1PM - 4PM CST

STI Update: STIs Throughout Pregnancy

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description: Faculty and staff from the St. Louis STI/HIV Prevention Training Center will discuss the realities of providing STI and sexual healthcare for our pregnant patients. Including but not limited to: case discussion, treatment options, & innovative ideas on sexual healthcare.

3 Day STI Intensive Course

OBJECTIVES 

1.  Identify the conditions most commonly seen included in the differential diagnosis of STIs

2.  Discuss the diagnosis, management, treatment and prevention of HIV

3.  Discuss methods for managing a patient presenting to a clinical setting infected with or at risk for an STI

4.  Describe the role of the disease intervention specialist (DIS) in STI control

CME and CNE

In support of improving patient care, this activity has been planned and implemented by the UAB Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The UAB Marnix E. Heersink School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The UAB Heersink School of Medicine designates this live activity for a maximum of 15.25 ANCC contact hours.

Dr. Anne Rompalo would like to disclose that their institution gets money from NIH.  They would also like to disclose that they get paid from Medscape for development of educational presentations and they get royalties from UpToDate.  Dr. Hamill would like to disclose that they get paid from Decera Clinical Education, they get an honorarium from UpToDate and they get royalties from UpToDate. Dr. Sue Tuddenham wishes to disclose that they get payment for development of educational presentations from University of Washington, they get Royalties for UpToDate.  They also would like to disclose that Hologic sends in kind donations test kits to the university.   Also, Dr. Tuddenham would like to state that they are an elected member of the board of the American Sexually Transmitted Disease Association and the International Union against Sexually Transmitted Infections.  Dr. Pinto wishes to disclose that their institution gets money from Hologic and Roche.  Also, they get their travel covered by Hologic. Also, Dr. Joyce Jones would like to disclose that their institution gets money from Gilead Sciences and Merck.

There is no commercial support for this activity.

*This course is on September 17 & 18 from 8AM-4:30PM CST both days.

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description:  This course, an intensive overview of STDs, includes 14 hours of lecture over two days.  Topics presented include gonorrhea, chlamydia, syphilis, trichomoniasis, PID, genital herpes, HPV, hepatitis B, chancroid, urethritis/cervicitis syndromes, pediculosis/ scabies, HIV/AIDS, prevention strategies / PrEP / EPT, and case studies.

Course Objectives:  At the end of this course, participants will be able to:

• Describe clinical features of reportable STDs: syphilis, gonorrhea, chlamydia.
• Understand current STD epidemiological patterns.
• Describe clinical features of common bacterial STDs:  syphilis, gonorrhea, chlamydia
• Recognize clinical presentations of common viral STDs:  genital herpes, HPV
• Demonstrate improved skills in completing STD history and physical exam.
• Discuss clinical characteristics of common vaginal infections:  trichomoniasis, bacterial vaginosis, candidiasis
• Integrate HIV risk assessment into patient care.
• Demonstrate universal precautions during specimen collection.
• Describe current approaches to STD/HIV prevention including pre-exposure prophylaxis and expedited partner therapy.
• Discuss evidence-based strategies for STD treatment, according to CDC’s STD Treatment Guidelines.